Cite
HARVARD Citation
Tanguay, J. et al. (2016). High Risk of Neutropenia for Hormone-naive Prostate Cancer Patients Receiving STAMPEDE-style Upfront Docetaxel Chemotherapy in Usual Clinical Practice. Clinical oncology. 28 (9), pp. 611-. [Online].